Skip to menu Skip to content Skip to footer

2013

Book Chapter

An overview of erythropoietin therapy

Zirapury, Tasnim, van Eps, Carolyn, Hawley, Carmel M., Badve, Sunil V. and Johnson, David W. (2013). An overview of erythropoietin therapy. Erythropoietin: human production, potential uses and adverse effects. (pp. 31-53) New York, NY, United States: Nova Science Publishers.

An overview of erythropoietin therapy

2013

Conference Publication

Prevalence of oral lesions in hemodialysis patients: the oral-D prospective multinational cohort study

Palmer, Suetonia, Ruospo, Marinella, Natale, Patrizia, Gargano, Letizia, Saglimbene, Valeria, Pellegrini, Fabio, Johnson, David W., Craig, Jonathan C., Hegbrant, Jorgen and Strippoli, Giovanni F. M. (2013). Prevalence of oral lesions in hemodialysis patients: the oral-D prospective multinational cohort study. 50th European Renal Association - European Dialysis and Transplant Association Congress, Istanbul, Turkey, May 18-21, 2013. Oxford, United Kingdom: Oxford University Press.

Prevalence of oral lesions in hemodialysis patients: the oral-D prospective multinational cohort study

2013

Journal Article

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial

Petchey, William G., Hickman, Ingrid J., Prins, Johannes B., Hawley, Carmel M., Johnson, David W. and Isbel, Nicole M. (2013). Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial. Nephrology, 18 (1), 26-35. doi: 10.1111/j.1440-1797.2012.01662.x

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial

2013

Conference Publication

Introducing Nxstage haemodialysis in the Australian home

Van Eps, C., Jeffires, J., Hawley, C., Johnson, D., Campbell, S., Isbel, N. and Mudge, D. (2013). Introducing Nxstage haemodialysis in the Australian home. 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Brisbane Convention and Exhibition Centre, Brisbane, Australia, 9-11 September 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12121

Introducing Nxstage haemodialysis in the Australian home

2013

Conference Publication

A Randomised, Controlled Trial of Exit Site Application of Medihoney for the Prevention of Catheter-Associated Infections in Pd Patients - Honeypot Study

Johnson, D., Badve, S., Pascoe, E., Beller, E., Cass, A., Clark, C., De Zoysa, J., Mctaggart, S., Isbel, N. and Morrish, A. (2013). A Randomised, Controlled Trial of Exit Site Application of Medihoney for the Prevention of Catheter-Associated Infections in Pd Patients - Honeypot Study. 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Brisbane, QLD Australia, 9-11 September 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12121

A Randomised, Controlled Trial of Exit Site Application of Medihoney for the Prevention of Catheter-Associated Infections in Pd Patients - Honeypot Study

2013

Conference Publication

Mitochondrial Homeostasis Is Impeded by Degradation and Autophagy in Oxidative Stress-Induced Renal Cell Injury

Small, David M., Bennett, Nigel C., Coombes, Jeff, Johnson, David W. and Gobe, Glenda C. (2013). Mitochondrial Homeostasis Is Impeded by Degradation and Autophagy in Oxidative Stress-Induced Renal Cell Injury. 50th European Renal Association European Dialysis and Transplant Association Congress, Istanbul Turkey, 18-21 May 2013. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gft114

Mitochondrial Homeostasis Is Impeded by Degradation and Autophagy in Oxidative Stress-Induced Renal Cell Injury

2013

Journal Article

HMG CoA reductase inhibitors (statins) for dialysis patients

Palmer, Suetonia C., Navaneethan, Sankar D., Craig, Jonathan C., Johnson, David W., Perkovic, Vlado, Nigwekar, Sagar U., Hegbrant, Jorgen and Strippoli, Giovanni F.M. (2013). HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database of Systematic Reviews, 2013 (9) CD004289. doi: 10.1002/14651858.CD004289.pub5

HMG CoA reductase inhibitors (statins) for dialysis patients

2013

Journal Article

Renal services disaster planning: lessons learnt from the 2011 Queensland floods and North Queensland cyclone experiences

Johnson, David W., Hayes, Bronwyn, Gray, Nicholas A., Hawley, Carmel, Hole, Janet and Mantha, Murty (2013). Renal services disaster planning: lessons learnt from the 2011 Queensland floods and North Queensland cyclone experiences. Nephrology, 18 (1), 41-46. doi: 10.1111/nep.12008

Renal services disaster planning: lessons learnt from the 2011 Queensland floods and North Queensland cyclone experiences

2013

Conference Publication

Utility of "back up" arterio-venous fistulas in patients on peritoneal dialysis and use of central lines: A comparison between two Australian centres

Rao, N., Borlace, M., Taylor, R., Matthew, Y., Jaffrey, L., Johnson, D., Mudge, D. and Bannister, K. (2013). Utility of "back up" arterio-venous fistulas in patients on peritoneal dialysis and use of central lines: A comparison between two Australian centres. 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Brisbane, Australia, 9-11 September 2013. Richmond, VIC Australia: Wiley-Blackwell.

Utility of "back up" arterio-venous fistulas in patients on peritoneal dialysis and use of central lines: A comparison between two Australian centres

2012

Journal Article

Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis

Rossi, Megan, Klein, Kerenaftali, Johnson, David W. and Campbell, Katrina L. (2012). Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis. International Journal of Nephrology, 2012 673631, 673631.1-673631.20. doi: 10.1155/2012/673631

Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis

2012

Journal Article

The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial

Johnson, David W., Brown, Fiona G., Clarke, Margaret, Boudville, Neil, Elias, Tony J., Foo, Marjorie W. Y., Jones, Bernard, Kulkarni, Hemant, Langham, Robyn, Ranganathan, Dwarakanathan, Schollum, John, Suranyi, Michael G., Tan, Seng H. and Voss, David (2012). The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial. Nephrology Dialysis Transplantation, 27 (12), 4445-4453. doi: 10.1093/ndt/gfs314

The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial

2012

Journal Article

Clinician beliefs and attitudes about home haemodialysis: a multinational interview study

Tong, Allison, Palmer, Suetonia, Manns, Braden, Craig, Jonathan C., Ruospo, Marinella, Gargano, Letizia, Johnson, David W., Hegbrant, Jorgen, Olsson, Mans, Fishbane, Steven and Strippoli, Giovanni F. M. (2012). Clinician beliefs and attitudes about home haemodialysis: a multinational interview study. BMJ Open, 2 (6) e002146, e002146.1-e002146 .12. doi: 10.1136/bmjopen-2012-002146

Clinician beliefs and attitudes about home haemodialysis: a multinational interview study

2012

Journal Article

End-stage kidney disease due to haemolytic uraemic syndrome – outcomes in 241 consecutive ANZDATA registry cases

Tang, Wen, Mohandas, Janaki, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil, Brown, Fiona G., Clayton, Philip A., Wiggins, Kathryn J., Bannister, Kym M., Campbell, Scott B. and Johnson, David W. (2012). End-stage kidney disease due to haemolytic uraemic syndrome – outcomes in 241 consecutive ANZDATA registry cases. BMC Nephrology, 13 (1) 164, 164.1-164.11. doi: 10.1186/1471-2369-13-164

End-stage kidney disease due to haemolytic uraemic syndrome – outcomes in 241 consecutive ANZDATA registry cases

2012

Journal Article

Frank-ter Haar syndrome associated with sagittal craniosynostosis and raised intracranial pressure

Bendon, Charlotte L., Fenwick, Aimee L., Hurst, Jane A., Nuernberg, Gudrun, Nuernberg, Peter, Wall, Steven A., Wilkie, Andrew O. M. and Johnson, David (2012). Frank-ter Haar syndrome associated with sagittal craniosynostosis and raised intracranial pressure. Bmc Medical Genetics, 13 104. doi: 10.1186/1471-2350-13-104

Frank-ter Haar syndrome associated with sagittal craniosynostosis and raised intracranial pressure

2012

Journal Article

Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week

Barraclough, Katherine A., Staatz, Christine E., Johnson, David W., Lee, Katie J., McWhinney, Brett C., Ungerer, Jacobus P. J., Hawley, Carmel M., Campbell, Scott B., Leary, Diana R. and Isbel, Nicole M. (2012). Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week. Transplant International, 25 (11), 1182-1193. doi: 10.1111/j.1432-2277.2012.01553.x

Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week

2012

Journal Article

Effect of timing of dialysis commencement on clinical outcomes of patients with planned initiation of peritoneal dialysis in the ideal trial

Johnson, David W., Wong, Muh Geot, Cooper, Bruce A., Branley, Pauline, Bulfone, Liliana, Collins, John F., Craig, Jonathan C., Fraenkel, Margaret B., Harris, Anthony, Kesselhut, Joan, Li, Jing Jing, Luxton, Grant, Pilmore, Andrew, Tiller, David J., Harris, David C. and Pollock, Carol A. (2012). Effect of timing of dialysis commencement on clinical outcomes of patients with planned initiation of peritoneal dialysis in the ideal trial. Peritoneal Dialysis International, 32 (6), 595-604. doi: 10.3747/pdi.2012.00046

Effect of timing of dialysis commencement on clinical outcomes of patients with planned initiation of peritoneal dialysis in the ideal trial

2012

Journal Article

NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation

Barraclough, Katherine A., Isbel, Nicole M., Lee, Katie J., Bergmann, Troels K., Johnson, David W., McWhinney, Brett C., Ungerer, Jacobus P. J., Campbell, Scott B., Leary, Diana R., Bialasiewicz, Seweryn, Rockett, Rebecca J. and Staatz, Christine E. (2012). NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation. Transplantation, 94 (10), 1025-1032. doi: 10.1097/TP.0b013e31826c3985

NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation

2012

Journal Article

A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial

Barraclough, Katherine A., Brown, Fiona, Hawley, Carmel M., Leary, Diana, Noble, Euan, Campbell, Scott B., Isbel, Nicole M., Mudge, David W., van Eps, Carolyn L. and Johnson, David W. (2012). A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial. Nephrology, Dialysis, Transplantation, 27 (11), 4146-4153. doi: 10.1093/ndt/gfs372

A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial

2012

Journal Article

A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients -- the HEALTHY-CATH trial

Broom, Jennifer K., Krishnasamy, Rathika, Hawley, Carmel M., Playford, Elliot G. and Johnson, David W. (2012). A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients -- the HEALTHY-CATH trial. BMC Nephrology, 13 (1 Article No.146) 146, 146. doi: 10.1186/1471-2369-13-146

A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients -- the HEALTHY-CATH trial

2012

Journal Article

Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis

Johnson, David W., Clayton, Philip, Cho, Yeoung Jee, Badve, Sunil V., Hawley, Carmel M., McDonald, Stephen, Boudville, Neil, Wiggins, Kathryn J., Bannister, Kym and Brown, Fiona (2012). Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis. Peritoneal Dialysis International, 32 (5), 516-524. doi: 10.3747/pdi.2011.00169

Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis